Cargando…

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma

BACKGROUND: Malignant glioma exerts a metabolic shift from oxidative phosphorylation (OXPHOs) to aerobic glycolysis, with suppressed mitochondrial functions. This phenomenon offers a proliferation advantage to tumor cells and decrease mitochondria-dependent cell death. However, the underlying mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Qiuyun, Yang, Wanchun, Zhang, Shuxin, Li, Tengfei, Zuo, Mingrong, Zhou, Xingwang, Li, Junhong, Li, Mao, Xia, Xiaoqiang, Chen, Mina, Liu, Yanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842075/ https://www.ncbi.nlm.nih.gov/pubmed/33509092 http://dx.doi.org/10.1186/s10020-020-00261-4

Ejemplares similares

Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide
por: Li, Tengfei, et al.
Publicado: (2020)

Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma
por: Chen, Siliang, et al.
Publicado: (2022)

Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas
por: Li, Junhong, et al.
Publicado: (2023)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
por: Chen, Siliang, et al.
Publicado: (2022)

Multiple Model Evaluation of the Masseteric-to-Facial Nerve Transfer for Reanimation of the Paralyzed Face and Quick Prognostic Prediction
por: Li, Tengfei, et al.
Publicado: (2022)

The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis
por: Labbé, Katherine, et al.
Publicado: (2021)

Different materials of cranioplasty for patients undergoing decompressive craniectomy: A protocol for systematic review and network meta-analysis
por: Yang, Wanchun, et al.
Publicado: (2021)

Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
por: Li, Junhong, et al.
Publicado: (2022)

Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma
por: Li, Junhong, et al.
Publicado: (2021)

APOC1 promotes the progression of osteosarcoma by binding to MTCH2
por: Li, Renjie, et al.
Publicado: (2023)

Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022)

Insertases Scramble Lipids: Molecular Simulations of MTCH2
por: Bartoš, Ladislav, et al.
Publicado: (2023)

MTCH2 is a mitochondrial outer membrane protein insertase
por: Guna, Alina, et al.
Publicado: (2022)

ETMM-06. ELEVATED MITOCHONDRIAL TOM20 EXPRESSION SUPPRESSES GLIOMA MALIGNANCY BY ENHANCING OXIDATIVE PHOSPHORYLATION
por: Li, Mao, et al.
Publicado: (2021)

Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas
por: Yuan, Yunbo, et al.
Publicado: (2023)

Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma
por: Chen, Guolin, et al.
Publicado: (2021)

Prognostic significance of preoperative systemic inflammation response index in newly diagnosed glioblastoma patients underwent gross total resection: a propensity score matching analysis
por: Wang, Zhihao, et al.
Publicado: (2022)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization study
por: Wang, Zhihao, et al.
Publicado: (2023)

Acquired temozolomide resistance in MGMT(low) gliomas is associated with regulation of homologous recombination repair by ROCK2
por: Zhang, Xin, et al.
Publicado: (2022)

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex
por: Djajawi, Tirta Mario, et al.
Publicado: (2020)

Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas
por: Li, Junhong, et al.
Publicado: (2022)

MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells
por: Bahat, Amir, et al.
Publicado: (2018)

Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice
por: Bar-Lev, Yamit, et al.
Publicado: (2016)

Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampal-dependent cognitive functions
por: Ruggiero, Antonella, et al.
Publicado: (2017)

Stop codon read-through of mammalian MTCH2 leading to an unstable isoform regulates mitochondrial membrane potential
por: Manjunath, Lekha E., et al.
Publicado: (2020)

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
por: Zhang, Shuxin, et al.
Publicado: (2022)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence
por: Berte, Nancy, et al.
Publicado: (2016)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells
por: Wang, Xuan, et al.
Publicado: (2023)

Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair
por: Christmann, Markus, et al.
Publicado: (2016)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
por: Cao, Yingxiao, et al.
Publicado: (2020)

SPDR-01 INHIBITION OF HOMOLOGOUS RECOMBINATION, PARP INHIBITOR, OR DIANHYDROGALACTITOL OVERCOMES TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS
por: Ohba, Shigeo, et al.
Publicado: (2019)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2012)

Clinical Significance of Preoperative Fibrinogen to Albumin Ratio in Patients with Glioblastoma: A Singe Center Experience
por: Li, Junhong, et al.
Publicado: (2021)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gt64ebrd67ku81ni52k0n1vibg